SML1662

Buparvaquon

≥98% (HPLC)

• Synonym(e): 2-[(4-tert.-Butylcyclohexyl)-methyl]-3-hydroxy-1,4-naphthochinon, 2-[[4-(1,1-Dimethylethyl)-cyclohexyl]-methyl]-3-hydroxy-1,4-naphthalindion
• Empirische Formel (Hill-System): C₂₁H₂₆O₃
• CAS-Nummer: 88426-33-9
• Molekulargewicht: 326.43
• MDL-Nummer: MFCD01712789
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329826000
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 200
• Assay: ≥98% (HPLC)
• Form: powder
• Löslichkeit: DMSO: soluble; chloroform: soluble
• Lagertemp.: 2-8°C
• SMILES String: CC(C)(C)C1CCC(CC1)CC2=C(O)C(=O)c3ccccc3C2=O
• InChI: 1S/C21H26O3/c1-21(2,3)14-10-8-13(9-11-14)12-17-18(22)15-6-4-5-7-16(15)19(23)20(17)24/h4-7,13-14,24H,8-12H2,1-3H3
• InChIKey: KLLIVCPQDTYMLC-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

Buparvaquone is a second-generation hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. Buparvaquone is indicated for the therapy and prophylaxis of all forms of Theileriosis and found to have an anti-Leishmanial activity.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable